Tissue Regenix Share Discussion Threads

[emeraldzebra] 21/11/2024 14:29

Thanks ali47. All clear. Reading between the lines
I think they’d just like a bit more clout
than they can manage given their present size.

[bamboo2] 21/11/2024 13:46

Could someone email IR to ask for it?

[bamboo2] 21/11/2024 12:20

PJ/anyone Re, "Tissue Regenix (AIM: TRX), notes the media speculation and confirms that it is conducting a review of the Company's strategic options that may include soliciting offers for the Company. As part of this, the Company has contacted a limited number of potential counterparties to assess whether such parties could put forward a proposal that would deliver greater value to Tissue Regenix's shareholders than pursuing a standalone independent strategy."
=============

Have we had sight of, or a link to the media speculation?

[ali47fish] 21/11/2024 11:58

the fact that they are looking for a buyer doesnt inspire confidence and the share price is stagnant or going backwards

[emeraldzebra] 21/11/2024 11:31

Ali47fish. “Untoward̶1;. Just wondering
What you mean there ? Thanks.

[pj84] 20/11/2024 19:18

Looks like a clarification of the notice first issued on 13 Nov with additional information on the breakdown of the 11.1% previously announced.

[pj84] 13/11/2024 11:33

Edit Looking back through the recent holdings RNS's it looks like 3 of the major holders have been increasing their holdings, so that Lombard now has a holding of 12.57% and Richard Griffiths has a holding of 11.1% and Richard Snellor (with his wife and Inthallo) now have a holding of 15.23% which suggests something is happening as Richard Griffiths and Lombard often work together, particularly following the RNS issued by the company on 4 Nov saying:-

"Tissue Regenix (AIM: TRX), notes the media speculation and confirms that it is conducting a review of the Company's strategic options that may include soliciting offers for the Company. As part of this, the Company has contacted a limited number of potential counterparties to assess whether such parties could put forward a proposal that would deliver greater value to Tissue Regenix's shareholders than pursuing a standalone independent strategy."

[cliffpeat] 13/11/2024 10:24

Richard Griffiths has increased holding by 1m+ shares compared to the data on the company website. Now 11.1%

[tnt99] 12/11/2024 19:16

Could this be an opening offer or buyout by the management? Seems ambiguous??!!!

[clocktower] 12/11/2024 16:11

I have ignored this for some time but just saw todays RNS.

What's been going on?

[tnt99] 06/11/2024 21:34

I'll take that

[onei] 06/11/2024 06:19

So a quick check for comparable transactions suggests a multiple of 4 to 5 times sales.

hxxps://www.healthcare.digital/single-post/average-multiples-in-healthtech-m-a-deals-april-2024?form=MG0AV3

Copilot says that Stryker's acquisition of SERF SAS and Artelon were part of recent transactions reflecting these multiples, but I haven't actually found the figures to check this.

Using the sales for the first half of 2024 and simply doubling that to get the annual sales and then using a multiple of 4 would equate to about 140p per share.

[carrotandstick] 05/11/2024 10:33

I remember Smith & Nephew being mentioned a few years back when there was talk of a manufacturing agreement. That said, I think J&J were mentioned too

[thebd11] 05/11/2024 09:35

Get the sense that this is a 'come get me' type post. When Sneller first went in I have it on reliable terms that this was discussed as a possible takeover target as one of the (but not the major) reasons for purchase. Similarly, when Sneller / Inthallo bought in (back in late Summer 22) and took enough of a stake to block Mills taking this private / pushing through a sale it wasn't exactly received well by Harwood! So I think all along the plan has been for this to be sold, though I note Mills saying a few months ago that there hadn't been any meaningful interest up until then, so I wonder if that's changed? Otherwise, this is I suppose a 'flush out' some bids development. Knowing the register, Mills, Richard S, Richard G @ Ora, LO etc - would imagine this won't be being sold on the cheap, but let's see!

[tnt99] 05/11/2024 07:27

Come on smith and nephew need 1.20 at least to break even!!!

[p1nkfish] 05/11/2024 03:11

No offeror but already on takeover panel list and certainly growth expected in their market. Perhaps it has been mentioned in some niche publication for regen medicine that's hard to find unless in the know.

[p1nkfish] 04/11/2024 19:40

Am in US currently.
Have searched, found nothing obvious over the past month time frame with US as location to search from.

[carrotandstick] 04/11/2024 18:34

Could be speculation in the US?

[bamboo2] 04/11/2024 17:27

I could find no media speculation with a quick google search.
It does look to me like an offer has been made. Maybe it's too low?

====================================================================

Response to media speculation

Tissue Regenix (AIM: TRX), notes the media speculation and confirms that it is conducting a review of the Company's strategic options that may include soliciting offers for the Company. As part of this, the Company has contacted a limited number of potential counterparties to assess whether such parties could put forward a proposal that would deliver greater value to Tissue Regenix's shareholders than pursuing a standalone independent strategy.



The Company has not received any indicative non-binding proposals to date.



There can be no certainty that any offer will be made as a result of contact with these potential counterparties, nor as to the terms on which any such offer might be made. Shareholders are advised to take no action at this time.



A further announcement will be made in due course.



Takeover Code notes

The Takeover Panel Executive has granted a dispensation from the requirement of Rules 2.4 (a) and (b) of the Takeover Code such that Tissue Regenix is not required to identify in this announcement any potential offeror with which the Company is in talks, or from which an approach has been received, unless that potential offeror has been specifically identified in any rumour or speculation.



As a consequence of this announcement, an 'offer period' has now commenced in respect of the Company in accordance with the Takeover Code, and the attention of shareholders is drawn to the disclosure requirements of Rule 8 of the Takeover Code, which are summarised below in "Disclosure Requirements of the Takeover Code".

[p1nkfish] 04/11/2024 17:10

Yes, won't scale alone quickly. Parent needed. For Sale sign up but no offers so far.

[cerrito] 04/11/2024 16:57

Anyone have an idea what this RNS is all about??
I go on the basis that some large shareholders are loosing patience.

[tnt99] 11/10/2024 14:17

Ten bagger here in the next two years my guess